ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer.

Yuting Sang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.